These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12118145)

  • 1. Current approaches to analgesic drug delivery for chronic pain.
    Carr DB; Sendil D
    Technol Health Care; 2002; 10(3-4):227-35. PubMed ID: 12118145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain.
    Nicholson B
    Pain Pract; 2009; 9(1):71-81. PubMed ID: 19019047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J; Sittl R
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy.
    Coluzzi F; Pappagallo M;
    Minerva Anestesiol; 2005; 71(7-8):425-33. PubMed ID: 16012415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal drug delivery.
    Smith HS; Deer TR; Staats PS; Singh V; Sehgal N; Cordner H
    Pain Physician; 2008 Mar; 11(2 Suppl):S89-S104. PubMed ID: 18443642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin.
    Prager JP
    Spine (Phila Pa 1976); 2002 Nov; 27(22):2593-605; discussion 2606. PubMed ID: 12435999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C; Failde I; Micó JA; Neira M; Sánchez-Magro I
    Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R; Kayser H; Sittl R
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative management of patients with an intrathecal drug delivery system for chronic pain.
    Grider JS; Brown RE; Colclough GW
    Anesth Analg; 2008 Oct; 107(4):1393-6. PubMed ID: 18806058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination analgesia in 2005 - a rational approach: focus on paracetamol-tramadol.
    Schug SA
    Clin Rheumatol; 2006; 25 Suppl 1():S16-21. PubMed ID: 16741784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery.
    Deer TR; Smith HS; Cousins M; Doleys DM; Levy RM; Rathmell JP; Staats PS; Wallace M; Webster LR
    Pain Physician; 2010; 13(3):E175-213. PubMed ID: 20495597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management.
    Fine PG; Mahajan G; McPherson ML
    Pain Med; 2009 Jul; 10 Suppl 2():S79-88. PubMed ID: 19691687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid analgesia: perspectives on right use and utility.
    Ballantyne JC
    Pain Physician; 2007 May; 10(3):479-91. PubMed ID: 17525783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary delivery of opioids as pain therapeutics.
    Farr SJ; Otulana BA
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1076-88. PubMed ID: 17070614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.
    Dunteman ED
    J Pain Palliat Care Pharmacother; 2005; 19(1):35-43. PubMed ID: 15814513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain.
    Janicki PK; Schuler G; Francis D; Bohr A; Gordin V; Jarzembowski T; Ruiz-Velasco V; Mets B
    Anesth Analg; 2006 Oct; 103(4):1011-7. PubMed ID: 17000822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting peroxynitrite driven nitroxidative stress with synzymes: A novel therapeutic approach in chronic pain management.
    Salvemini D; Neumann W
    Life Sci; 2010 Apr; 86(15-16):604-14. PubMed ID: 19576230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.